COST

981.52

-0.32%↓

162.5

+1.06%↑

80.15

+0.4%↑

185.74

+1.26%↑

PEP

166.78

+1.15%↑

COST

981.52

-0.32%↓

162.5

+1.06%↑

80.15

+0.4%↑

185.74

+1.26%↑

PEP

166.78

+1.15%↑

COST

981.52

-0.32%↓

162.5

+1.06%↑

80.15

+0.4%↑

185.74

+1.26%↑

PEP

166.78

+1.15%↑

COST

981.52

-0.32%↓

162.5

+1.06%↑

80.15

+0.4%↑

185.74

+1.26%↑

PEP

166.78

+1.15%↑

COST

981.52

-0.32%↓

162.5

+1.06%↑

80.15

+0.4%↑

185.74

+1.26%↑

PEP

166.78

+1.15%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Open

BrancheKonsumgüter defensiv

7.03 29.47

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

6.92

Max

7.06

Schlüsselkennzahlen
By Trading Economics
Einkommen	-7.9M -10M
Verkäufe	-5.3M 31M
Gewinnspanne	-32.116
Angestellte	406

Dividenden
By Dow Jones
Nächstes Ergebnis	27. Feb. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-16M 225M
Vorheriger Eröffnungskurs	-22.44
Vorheriger Schlusskurs	7.03

Nachrichtenstimmung

By Acuity

25%

75%

14 / 132 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Feb. 2026, 23:55 UTC

Market Talk

Gold and Silver Rise Amid Renewed Trade Tensions -- Market Talk

22. Feb. 2026, 23:53 UTC

Market Talk

Japan Activity Data Set to Show Strength, Backed by Fiscal Spending -- Market Talk

22. Feb. 2026, 23:53 UTC

Market Talk

Key China Rates Likely to Be Held Steady for Now -- Market Talk

22. Feb. 2026, 23:51 UTC

Market Talk

Bank of Korea Set to Hold Fire as Inflation Steadies, Risks Linger -- Market Talk

22. Feb. 2026, 23:35 UTC

Market Talk

Oil Falls Amid Prospect That U.S. Strike on Iran Might Be Limited -- Market Talk

22. Feb. 2026, 23:21 UTC

Ergebnisse

Nickel Industries 2025 Adjusted Ebitda US$283.0 Million

22. Feb. 2026, 23:20 UTC

Ergebnisse

Nickel Industries 2025 Operating Profit US$126.4 Million

22. Feb. 2026, 23:19 UTC

Ergebnisse

Nickel Industries 2025 Revenue US$1.65 Billion, Down 5.5% On-Year

22. Feb. 2026, 23:19 UTC

Ergebnisse

Correct: Nickel Industries 2025 Net Loss US$57.1 Million, Down 66% On-Year

22. Feb. 2026, 23:18 UTC

Ergebnisse

Nickel Industries Won't Pay a Final Dividend

22. Feb. 2026, 23:16 UTC

Ergebnisse

Nickel Industries 2025 Net Loss A$57.1 Million, Down 66% On-Year

22. Feb. 2026, 21:35 UTC

Ergebnisse

Ampol Expects to Start Commissioning of Ultra Low Sulfur Fuels Project in 2Q

22. Feb. 2026, 21:34 UTC

Ergebnisse

Ampol Says F&I Australia, International Have Begun 2026 Strongly

22. Feb. 2026, 21:34 UTC

Ergebnisse

Ampol Expects Stage 1 of Fuel Security Services Payment Review Finalized in 1Q

22. Feb. 2026, 21:33 UTC

Ergebnisse

Ampol Says Lytton Refiner Margin Was US$8.13/bbl in January

22. Feb. 2026, 21:33 UTC

Ergebnisse

Ampol Recognizes A$89.9 Million Impairment in Carrying Value of Investment in Seaoil

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol Final Dividend A$0.60/Share

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol FY Revenue A$31.37 Billion, Down 10%

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol FY Replacement-Cost Net Profit A$429.2 Million, Up 83%

22. Feb. 2026, 21:28 UTC

Ergebnisse

Ampol FY Historical-Cost Net Profit A$82.4 Million, Down 33%

21. Feb. 2026, 14:31 UTC

Akquisitionen, Fusionen, Übernahmen

Bridgewater Associates' 4Q Buying and Selling -- Barrons.com

21. Feb. 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

20. Feb. 2026, 23:12 UTC

Akquisitionen, Fusionen, Übernahmen

FERC Authorizes TXNM Energy Acquisition by Blackstone Infrastructure

20. Feb. 2026, 22:12 UTC

Ergebnisse

Equinox Gold: Announces Filing of 2025 Audited Fincl Statements

20. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

20. Feb. 2026, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

20. Feb. 2026, 21:23 UTC

Ergebnisse

These Stocks Are Today's Movers: Grail, Corning, Comfort Systems USA, Opendoor, Akamai, Chemours, and More -- Barrons.com

20. Feb. 2026, 21:20 UTC

Market Talk

Century Aluminum Backs Trump's Tariffs After SCOTUS Ruling -- Market Talk

20. Feb. 2026, 21:01 UTC

Akquisitionen, Fusionen, Übernahmen

Want to Win the Warner Bros. Discovery Takeover Battle? 'Walk Away Now.' -- Barrons.com

20. Feb. 2026, 20:38 UTC

Market Talk

U.S. Natural Gas Gains Ahead of Chilly Weekend -- Market Talk

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Rating-Konsens

By TipRanks

Buy

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

14 / 132 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.